發(fā)布時間：2018-04-09 12:20

  本文選題：膿毒癥　切入點：鹽酸右美托咪定　出處：《中華醫(yī)院感染學雜志》2017年03期

【摘要】：目的探討鹽酸右美托咪定對膿毒癥患者圍手術期血清白細胞介素-10(Interleukin-10,IL-10)、白細胞介素-6(Interleukin-6,IL-6)、腫瘤壞死因子-α(Tumor necrosis factor-α,TNF-α)及高遷移率族蛋白B1(High mobility group protein B1,HMGB1)的影響。方法選擇醫(yī)院2014年1月-2015年12月需手術治療的膿毒癥患者94例為研究對象,將其分為右美托咪定組和對照組,每組各47例,右美托咪定組患者麻醉過程中靜脈泵入鹽酸右美托咪定,對照組靜脈泵入等量生理鹽水,采用ELISA法測定血清IL-10、IL-6、TNF-α和HMGB1水平。結果兩組患者手術結束時和術后24h血清IL-10水平均高于麻醉誘導前和手術1h(P0.05);與對照組比較,右美托咪定組手術結束時和術后24h血清IL-10水平明顯高于對照組(P0.05);兩組患者手術結束時和術后24h血清IL-6、TNF-α和HMGB1水平均高于麻醉誘導前和手術1h(P0.05);與對照組比較,右美托咪定組手術結束時和術后24h血清IL-6、TNF-α和HMGB1水平明顯低于對照組(P0.05)。結論膿毒癥患者圍手術期血清IL-10、IL-6、TNF-α和HMGB1水平均升高,右美托咪定可以降低血清IL-6、TNF-α和HMGB1水平,升高血清IL-10。
[Abstract]:Objective to investigate dexmedetomidine hydrochloride on perioperative serum IL-2 in patients with sepsis in -10 (Interleukin-10, IL-10), interleukin -6 (Interleukin-6, IL-6), tumor necrosis factor alpha (Tumor alpha factor- alpha necrosis, TNF-) and high mobility group protein B1 (High mobility group protein B1, HMGB1). The influence of selection method of hospital in January 2014 -2015 year in December the need for surgical treatment of the patients with sepsis and 94 cases as the research object, which can be divided into dexmedetomidine group and control group, 47 cases in each group, dexmedetomidine during intravenous infusion of dexmedetomidine hydrochloride group anesthesia control group, intravenous infusion of normal saline, serum IL-10 was determined by ELISA method, IL-6, TNF- alpha and HMGB1 level. Results in the end of two groups of patients with surgery and postoperative 24h serum level of IL-10 was higher than that before induction of anesthesia and surgery 1H (P0.05); compared with the control group, dexmedetomidine group At the end of 24h and postoperative serum IL-10 levels were significantly higher than the control group (P0.05); the end of the two groups of patients with operation time and postoperative serum 24h IL-6, TNF- alpha and HMGB1 was higher than before the induction of anesthesia and surgery 1H (P0.05); compared with the control group, dexmedetomidine group at the end of surgery and 24h after surgery serum IL-6, TNF- and HMGB1 levels were significantly lower than the control group (P0.05). Serum IL-10, perioperative sepsis patients conclusion during IL-6, TNF- and HMGB1 levels were elevated, dexmedetomidine can reduce the serum levels of IL-6, TNF- and HMGB1 levels, elevated serum IL-10.

【作者單位】： 義烏市中心醫(yī)院麻醉科;
【基金】：浙江省醫(yī)藥衛(wèi)生一般研究計劃基金資助項目(2014KYB297)
【分類號】：R614

【相似文獻】

相關期刊論文 前10條

1 童武華;王海波;張繼松;殳儆;王黎恩;曹偉中;陸佩文;施云超;;膿毒癥患者血清高密度脂蛋白膽固醇濃度變化的分析[J];中國綜合臨床;2006年03期

2 明自強;俞林明;呂銀祥;呂少明;王黎衛(wèi);王映紅;;膿毒癥患者氧利用率的變化與預后關系[J];中國中西醫(yī)結合急救雜志;2006年04期

3 羅良劍;何元明;;創(chuàng)傷后膿毒癥患者血脂水平的臨床研究[J];實用醫(yī)學雜志;2010年02期

4 吳遠怡;何祥英;謝曉紅;朱永;麥葉;;膿毒癥患者血脂水平的臨床研究[J];現(xiàn)代預防醫(yī)學;2012年14期

5 張近波;許國斌;張小樂;董美平;朱金強;史朝紅;鄢來超;曹烈祥;吳仙丹;王文龍;董志兵;;可溶性尿激酶型纖溶酶原激活物受體預測呼吸機相關性肺炎并發(fā)膿毒癥患者預后的研究[J];中華醫(yī)院感染學雜志;2012年19期

6 秦龍;張穎萍;劉秋e，

本文編號：1726421